(RTTNews) - Lantheus Holdings, Inc. (LNTH) announced the FDA has approved the supplemental new drug application for DEFINITY as an ultrasound enhancing agent for use in pediatric patients with ...

N. BILLERICA, Mass.--(BUSINESS WIRE)-- Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced that the U.S. Food and Drug Administration (FDA) has accepted ...

Lantheus Holdings, Inc. LNTH recently announced that the FDA has approved the supplemental new drug application for DEFINITY (Perflutren Lipid Microsphere) as an ultrasound-enhancing agent for use in ...